Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

16.29

-0.19 (-1.15%)

At close: Aug 28, 2026, 4:00 PM EDT

16.35

+0.06 (0.37%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Aurinia Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	311.51	283.06	235.13	175.51	134.03	45.61
Revenue Growth	19.76%	20.38%	33.97%	30.95%	193.89%	-9.01%
Cost of Revenue	68.89	65.17	49.03	63.79	50.65	52.23
Gross Profit	242.61	217.89	186.1	111.72	83.38	-6.63
Selling, General & Admin	100.97	101.79	172.03	195.04	196.37	173.54
Other Operating Expenses	-19.8	-0.17	1.55	2.48	-1.52	0.57
Operating Expenses	82.17	101.62	173.58	197.52	194.85	174.11
Operating Income	160.45	116.26	12.52	-85.79	-111.47	-180.74
Interest Expense	-4.11	-4.33	-4.84	-2.78	-	-
Interest & Investment Income	13.72	13.57	16.97	17	5.12	0.53
Currency Exchange Gain (Loss)	-9.7	-9.7	5.9	-5.9	-	-
EBT Excluding Unusual Items	160.36	115.8	30.55	-77.47	-106.35	-180.21
Merger & Restructuring Charges	-	-1.65	-23.11	-	-	-
Pretax Income	160.36	114.16	7.45	-77.47	-106.35	-180.21
Income Tax Expense	-153.75	-173.05	1.7	0.55	1.83	0.76
Net Income	314.11	287.2	5.75	-78.02	-108.18	-180.97
Net Income to Common	314.11	287.2	5.75	-78.02	-108.18	-180.97
Net Income Growth	418.03%	4893.08%	-	-	-	-
Shares Outstanding (Basic)	132	134	143	143	142	129
Shares Outstanding (Diluted)	136	139	146	143	142	129
Shares Change	-5.66%	-5.13%	2.07%	0.93%	9.70%	9.20%
EPS (Basic)	2.39	2.14	0.04	-0.54	-0.76	-1.40
EPS (Diluted)	2.30	2.07	0.04	-0.54	-0.76	-1.40
EPS Growth	447.94%	5075.00%	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	175.07	135.41	44.11	-34.18	-79.82	-158
Free Cash Flow Per Share	1.28	0.98	0.30	-0.24	-0.56	-1.22
Gross Margin	77.88%	76.98%	79.15%	63.66%	62.21%	-14.53%
Operating Margin	51.51%	41.07%	5.32%	-48.88%	-83.17%	-396.31%
Profit Margin	100.84%	101.47%	2.45%	-44.45%	-80.71%	-396.81%
Free Cash Flow Margin	56.20%	47.84%	18.76%	-19.47%	-59.55%	-346.44%
EBITDA	179.83	135.71	31.96	-74.14	-108.76	-177.97
EBITDA Margin	57.73%	47.95%	13.59%	-42.24%	-81.15%	-
D&A For EBITDA	19.38	19.45	19.45	11.65	2.71	2.76
EBIT	160.45	116.26	12.52	-85.79	-111.47	-180.74
EBIT Margin	51.51%	41.07%	5.32%	-48.88%	-83.17%	-
Effective Tax Rate	-	-	22.77%	-	-	-
Revenue as Reported	311.51	283.06	235.13	175.51	134.03	45.61

SEC Filings: 10-K · 10-Q